Journal
FUTURE ONCOLOGY
Volume 5, Issue 9, Pages 1429-1440Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/FON.09.103
Keywords
c-fms proto-oncogene; CSF-1; epithelial ovarian cancer; HuR; invasion; metastasis; post-transcriptional; regulation; urokinase
Categories
Funding
- NIH [NIHCA60665]
Ask authors/readers for more resources
Despite the dismal outcome seen in the majority of epithelial ovarian cancer patients, there is ongoing progress in understanding the disease at a molecular level. Elucidation of pathways underlying disease progression and metastasis of ovarian cancer is key to development of targeted therapeutics. It is only in this way that therapeutic potential can be translated to reality. Here, we describe the evidence to date for the role of CSF-1/c-fms signaling in ovarian cancer invasiveness and metastasis, including the recent understanding of how CSF-1/c-fms expression is regulated with identification of significant post-transcriptional regulators.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available